These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 31557953)

  • 1. Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review.
    Zhang Z; Mocanu V; Cai C; Dang J; Slater L; Deehan EC; Walter J; Madsen KL
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31557953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials.
    Proença IM; Allegretti JR; Bernardo WM; de Moura DTH; Ponte Neto AM; Matsubayashi CO; Flor MM; Kotinda APST; de Moura EGH
    Nutr Res; 2020 Nov; 83():1-14. PubMed ID: 32987284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial.
    Zhang Z; Mocanu V; Deehan EC; Hotte N; Zhu Y; Wei S; Kao DH; Karmali S; Birch DW; Walter J; Madsen KL
    Gut Microbes; 2024; 16(1):2345134. PubMed ID: 38685731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial.
    Yu EW; Gao L; Stastka P; Cheney MC; Mahabamunuge J; Torres Soto M; Ford CB; Bryant JA; Henn MR; Hohmann EL
    PLoS Med; 2020 Mar; 17(3):e1003051. PubMed ID: 32150549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplantation in obesity metabolism: A meta analysis and systematic review.
    Zecheng L; Donghai L; Runchuan G; Yuan Q; Qi J; Yijia Z; Shuaman R; Xiaoqi L; Yi W; Ni M; Yijin Q; Liang P; Jun W
    Diabetes Res Clin Pract; 2023 Aug; 202():110803. PubMed ID: 37356723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy.
    Kang Y; Cai Y
    Hormones (Athens); 2017 Jul; 16(3):223-234. PubMed ID: 29278509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition.
    Kootte RS; Levin E; Salojärvi J; Smits LP; Hartstra AV; Udayappan SD; Hermes G; Bouter KE; Koopen AM; Holst JJ; Knop FK; Blaak EE; Zhao J; Smidt H; Harms AC; Hankemeijer T; Bergman JJGHM; Romijn HA; Schaap FG; Olde Damink SWM; Ackermans MT; Dallinga-Thie GM; Zoetendal E; de Vos WM; Serlie MJ; Stroes ESG; Groen AK; Nieuwdorp M
    Cell Metab; 2017 Oct; 26(4):611-619.e6. PubMed ID: 28978426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time.
    de Groot P; Scheithauer T; Bakker GJ; Prodan A; Levin E; Khan MT; Herrema H; Ackermans M; Serlie MJM; de Brauw M; Levels JHM; Sales A; Gerdes VE; Ståhlman M; Schimmel AWM; Dallinga-Thie G; Bergman JJ; Holleman F; Hoekstra JBL; Groen A; Bäckhed F; Nieuwdorp M
    Gut; 2020 Mar; 69(3):502-512. PubMed ID: 31147381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation.
    Marotz CA; Zarrinpar A
    Yale J Biol Med; 2016 Sep; 89(3):383-388. PubMed ID: 27698622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome.
    van der Vossen EWJ; Bastos D; Stols-Gonçalves D; de Goffau MC; Davids M; Pereira JPB; Li Yim AYF; Henneman P; Netea MG; de Vos WM; de Jonge W; Groen AK; Nieuwdorp M; Levin E
    Gut Microbes; 2021; 13(1):1993513. PubMed ID: 34747338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?
    Aron-Wisnewsky J; Clément K; Nieuwdorp M
    Curr Diab Rep; 2019 Jun; 19(8):51. PubMed ID: 31250122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota transplantation in metabolic syndrome: History, present and future.
    de Groot PF; Frissen MN; de Clercq NC; Nieuwdorp M
    Gut Microbes; 2017 May; 8(3):253-267. PubMed ID: 28609252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Fecal Microbiome Transfer in Adolescents With Obesity: The Gut Bugs Randomized Controlled Trial.
    Leong KSW; Jayasinghe TN; Wilson BC; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
    JAMA Netw Open; 2020 Dec; 3(12):e2030415. PubMed ID: 33346848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis
    Liu MT; Huang YJ; Zhang TY; Tan LB; Lu XF; Qin J
    World J Gastroenterol; 2019 Jul; 25(27):3590-3606. PubMed ID: 31367159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial.
    Mocanu V; Zhang Z; Deehan EC; Kao DH; Hotte N; Karmali S; Birch DW; Samarasinghe KK; Walter J; Madsen KL
    Nat Med; 2021 Jul; 27(7):1272-1279. PubMed ID: 34226737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity.
    Wilson BC; Vatanen T; Jayasinghe TN; Leong KSW; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Holland DJ; Cutfield WS; O'Sullivan JM
    Microbiome; 2021 May; 9(1):107. PubMed ID: 33985595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fecal microbiota transplantation in metabolic syndrome: A meta-analysis of randomized controlled trials.
    Qiu B; Liang J; Li C
    PLoS One; 2023; 18(7):e0288718. PubMed ID: 37471410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of fecal microbiota transplantation with capsules on the prevention of metabolic syndrome among patients with obesity.
    Allegretti JR; Kassam Z; Hurtado J; Marchesi JR; Mullish BH; Chiang A; Thompson CC; Cummings BP
    Hormones (Athens); 2021 Mar; 20(1):209-211. PubMed ID: 33420959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients.
    Allegretti JR; Kassam Z; Mullish BH; Chiang A; Carrellas M; Hurtado J; Marchesi JR; McDonald JAK; Pechlivanis A; Barker GF; Miguéns Blanco J; Garcia-Perez I; Wong WF; Gerardin Y; Silverstein M; Kennedy K; Thompson C
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):855-863.e2. PubMed ID: 31301451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.